Sunshine Biopharma Inc. (SBFM)
About Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $36.3M
- Net income
- -$6.0M
- Total assets
- $30.1M
- Market cap
- $4.0M
- Gross margin
- 33.8%
- Operating margin
- -17.2%
- Net margin
- -16.5%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $36.3M
- Cost of revenue
- $24.1M
- Gross profit
- $12.3M
- Operating expenses
- $18.5M
- Operating income
- -$6.2M
- Income tax
- $21.6K
- Net income
- -$6.0M
- EPS (basic)
- $-1.44
Balance sheet
- Total assets
- $30.1M
- Current assets
- $26.9M
- Total liabilities
- $7.0M
- Current liabilities
- $6.4M
- Shareholders’ equity
- $23.0M
Cash flow
- Operating cash flow
- -$5.3M
- Investing cash flow
- -$836.3K
- Financing cash flow
- $4.7M
- Net cash flow
- -$1.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.0M
- Shares outstanding
- 2.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 9, 2007
Sunshine Biopharma Inc. (SBFM) Stock Price
- Reported a net loss of $6.0M in FY2025.
- Revenue grew 735% from FY2022 to FY2025.
- Gross margin of 33.8%, net margin -16.5%.
- Trading 92% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Sunshine Biopharma Inc..
Write a review
News about Sunshine Biopharma Inc.
News & sentiment via Polygon.io
Sunshine Biopharma Inc.: frequently asked questions
Is Sunshine Biopharma Inc. an American company?
Sunshine Biopharma Inc. is a US-based company headquartered in Fort Lauderdale, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Sunshine Biopharma Inc. headquartered?
Sunshine Biopharma Inc. is headquartered in Fort Lauderdale, Florida, United States.
Is Sunshine Biopharma Inc. publicly traded?
Yes — Sunshine Biopharma Inc. is a publicly traded company. Its stock trades under the ticker symbol SBFM on the NASDAQ.
What does Sunshine Biopharma Inc. do?
Sunshine Biopharma Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
